
    
      Key Inclusion Criteria

        1. Documented HIV RNA >1000 copies/ml

        2. Subject naïve to ARV. .

        3. Subject has indication to receive an antiretroviral regimen, based on local guidelines.

        4. Able to provide informed consent and agree to use a highly effective non-hormonal method
           of contraception

      Key Exclusion Criteria

        1. Evidence of resistance to Darunavir and/or FTC or 3TC or TDF based on the resistance
           test

        2. Patient with chronic hepatitis B

        3. Subject has a currently active AIDS defining illness (Category C conditions according to
           the CDC Classification System

        4. Required use of disallowed concomitant therapies

        5. Subject with the grade 3 or 4 laboratory abnormalities as defined by DAIDS grading table

      Primary Objective

      • Proportion of patients with HIV-1 RNA levels of less than 50 copies/mL at week 48 (ITT
      analysis, Snapshot analysis)
    
  